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Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology
characteristic of amyotrophic lateral sclerosis in neuronal cells
Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing neurodegenerative disorder and the
majority of ALS is sporadic, where misfolding and aggregation of Cu/Zn-superoxide dismutase (SOD1) is a
feature shared with familial mutant-SOD1 cases. ALS is characterized by progressive neurospatial spread of
pathology among motor neurons, and recently the transfer of extracellular, aggregated mutant SOD1 between
cells was demonstrated in culture. However, there is currently no evidence that uptake of SOD1 into cells
initiates neurodegenerative pathways reminiscent of ALS pathology. Similarly, whilst dysfunction to the ERGolgi compartments is increasingly implicated in the pathogenesis of both sporadic and familial ALS, it
remains unclear whether misfolded, wildtype SOD1 triggers ER-Golgi dysfunction. In this study we show that
both extracellular, native wildtype and mutant SOD1 are taken up by macropinocytosis into neuronal cells.
Hence uptake does not depend on SOD1 mutation or misfolding. We also demonstrate that purified mutant
SOD1 added exogenously to neuronal cells inhibits protein transport between the ER-Golgi apparatus,
leading to Golgi fragmentation, induction of ER stress and apoptotic cell death. Furthermore, we show that
extracellular, aggregated, wildtype SOD1 also induces ER-Golgi pathology similar to mutant SOD1, leading
to apoptotic cell death. Hence extracellular misfolded wildtype or mutant SOD1 induce dysfunction to ERGolgi compartments characteristic of ALS in neuronal cells, implicating extracellular SOD1 in the spread of
pathology among motor neurons in both sporadic and familial ALS.
Keywords

sod1, mutant, wildtype, extracellular, neuronal, amyotrophic, lateral, sclerosis, cells, characteristic, pathology,
golgi, er, induces, CMMB
Disciplines

Medicine and Health Sciences | Social and Behavioral Sciences
Publication Details

Sundaramoorthy, V., Walker, A. K., Yerbury, J., Soo, K., Farg, M. A., Hoang, V., Zeineddine, R., Spencer, D. &
Atkin, J. D. (2013). Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of
amyotrophic lateral sclerosis in neuronal cells. Cellular and Molecular Life Sciences, 70 (21), 4181-4195.
Authors

Vinod Sundaramoorthy, Adam K. Walker, Justin J. Yerbury, Kai Ying Soo, Manal A. Farg, Vy Hoang, Rafaa
Zeineddine, Damian Spencer, and Julie D. Atkin

This journal article is available at Research Online: http://ro.uow.edu.au/smhpapers/1183

Cellular and Molecular Life Sciences

Extracellular wildtype and mutant SOD1 induces ER–Golgi
pathology characteristic of amyotrophic lateral sclerosis
in neuronal cells
Vinod Sundaramoorthy · Adam K. Walker · Justin Yerbury ·
Kai Ying Soo · Manal A. Farg · Vy Hoang · Rafaa Zeineddine ·
Damian Spencer · Julie D. Atkin

Abstract amyotrophic lateral sclerosis (aLS) is a fatal
and rapidly progressing neurodegenerative disorder and the
majority of aLS is sporadic, where misfolding and aggregation of Cu/Zn-superoxide dismutase (SOD1) is a feature
shared with familial mutant-SOD1 cases. aLS is characterized by progressive neurospatial spread of pathology
among motor neurons, and recently the transfer of extracellular, aggregated mutant SOD1 between cells was demonstrated in culture. however, there is currently no evidence
that uptake of SOD1 into cells initiates neurodegenerative
pathways reminiscent of aLS pathology. Similarly, whilst
dysfunction to the eR–Golgi compartments is increasingly
implicated in the pathogenesis of both sporadic and familial aLS, it remains unclear whether misfolded, wildtype
SOD1 triggers eR–Golgi dysfunction. In this study we

show that both extracellular, native wildtype and mutant
SOD1 are taken up by macropinocytosis into neuronal
cells. hence uptake does not depend on SOD1 mutation
or misfolding. We also demonstrate that purified mutant
SOD1 added exogenously to neuronal cells inhibits protein transport between the eR–Golgi apparatus, leading to
Golgi fragmentation, induction of eR stress and apoptotic
cell death. Furthermore, we show that extracellular, aggregated, wildtype SOD1 also induces eR–Golgi pathology
similar to mutant SOD1, leading to apoptotic cell death.
hence extracellular misfolded wildtype or mutant SOD1
induce dysfunction to eR–Golgi compartments characteristic of aLS in neuronal cells, implicating extracellular
SOD1 in the spread of pathology among motor neurons in
both sporadic and familial aLS.
Keywords extracellular · SOD1 · aLS · endoplasmic
reticulum · Golgi
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Introduction
amyotrophic lateral sclerosis (aLS) is a neurodegenerative
disorder with focal onset followed by progressive spread
throughout surrounding upper and lower motor neurons.
the intercellular transfer of misfolded proteins has recently
been demonstrated in several neurodegenerative diseases,
including aLS [1–3], and it has been suggested that this
mechanism is responsible for the progressive spread of
pathology. Mutations in SOD1 (Cu/Zn-superoxide dismutase) cause 20 % of familial aLS, and these cases display similar clinical features and pathogenesis to sporadic
aLS, which accounts for 90 % of all aLS cases. Misfolded
and aggregated SOD1 is present in both familial and sporadic aLS, but its pathobiology remains unclear [4, 5].
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however, endoplasmic reticulum (eR) stress and fragmentation of the Golgi apparatus are well-described features
in human aLS patients as well as in animal and cellular
disease models [6–9]. eR stress is triggered initially in the
most vulnerable motor neurons during early disease stages
in several lines of transgenic mutant SOD1 mice, thus
implying an active role in neurodegeneration [8].
Wildtype SOD1 (SOD1Wt) misfolds upon pathogenic
triggers such as oxidative stress, and misfolded SOD1Wt
exhibits similar toxic properties to mutant SOD1 [4].
Oxidized, misfolded SOD1Wt is present in the intracellular inclusions in motor neurons of sporadic aLS patients
[5, 10]. Furthermore, recently it was shown that transgenic overexpression of SOD1Wt causes aLS in mice
[11]. together these data suggest that misfolded SOD1Wt
could play a similar role to mutant SOD1 in the pathogenesis of sporadic aLS. there is accumulating evidence that
secreted, extracellular SOD1, which is misfolded either
due to mutation or cellular stress, could be a toxic factor spreading neurodegeneration among motor neurons in
aLS. SOD1 is secreted by neuronal cells [12, 13] and is
present in the cerebrospinal fluid (CSF) of aLS patients
[14, 15]. aggregated mutant SOD1 can be taken up by cells
via macropinocytosis which triggers subsequent aggregation of natively folded SOD1 [1]. Similarly, extracellular
misfolded SOD1Wt induces cell death [16] and overexpression of SOD1Wt induces misfolding of natively folded
SOD1 in human but not mouse neuronal cell lines, demonstrating species specificity in the transfer of misfolding
[17]. Furthermore, therapeutic strategies targeting extracellular SOD1 using antibodies specific to misfolded SOD1,
delay disease progression in mutant SOD1 transgenic mice
[18–20]. however, there is currently no evidence to show
that uptake of extracellular misfolded SOD1 into neuronal
cells initiates neurodegenerative pathways reminiscent of
aLS pathology. It also remains unclear if both natively
folded and misfolded forms of SOD1Wt and mutant SOD1
can be taken up by neurons.
eR stress triggers the unfolded protein response (UPR),
a set of signaling pathways that activate sensor proteins
including inositol requiring kinase 1 (IRe1), activating
transcription factor 6 (atF-6) and x-box binding protein 1
(Xbp1) [21]. activation of UPR leads to down-regulation
of general protein expression and upregulation of specific
eR chaperones including immunoglobulin binding protein
(BiP) and protein disulfide isomerase (PD1). BiP plays
a key role in regulating induction of eR stress [22]. this
leads to the upregulation and activation of IRe1, which
mediates the splicing of Xbp1. Whilst initially protective,
prolonged eR stress initiates apoptosis by activating ChOP
(C/eBP homologous protein) [21], a transcription factor
which translocates to the nucleus upon activation. Whilst
eR stress is now recognized as an important pathogenic

feature of aLS, the mechanism by which mutant SOD1
activates the UPR is not fully defined, but includes binding of mutant SOD1 to Derlin-1 at least by symptom onset
in transgenic SOD1 mice [22]. Conventionally eR stress is
triggered when misfolded proteins accumulate within eR,
but SOD1 is predominately cytoplasmic [23]. however, eR
stress can also be triggered by inhibition of protein transport between eR and Golgi apparatus [24, 25]. Inhibition
of eR–Golgi transport implies disruption to the secretory
pathway, and Golgi fragmentation is another pathological
feature of aLS, observed in both human patients and cellular and animal disease models [9, 26]. Likewise, the Golgi
apparatus can fragment due to defects in eR to Golgi trafficking [27].
In this study, we examined whether extracellular, misfolded SOD1Wt and mutant G93a SOD1 (SOD1G93a)
activate cellular events characteristic of aLS pathology after uptake into neurons. aggregated SOD1Wt and
SOD1G93a proteins were taken up into mouse NSC-34
and human Sh-SY5Y neuronal cells, leading to eR stress,
Golgi fragmentation, and inhibition of eR–Golgi protein
trafficking. apoptotic cell death was also triggered in
Sh-SY5Y cells. Furthermore, natively folded SOD1Wt
was taken up by both cell lines, demonstrating that
uptake is not specific to mutation or misfolding of SOD1.
hence extracellular misfolded SOD1Wt and SOD1G93a
induce cellular pathology characteristic of aLS, providing evidence for cell-to-cell transfer of SOD1 mediated
neurotoxicity.

Results
Uptake of extracellular SOD1Wt and SOD1G93a
by neuronal cells
In order to examine the cell-to-cell propagation of SOD1,
we first analyzed the uptake of extracellular SOD1 by
mouse (NSC-34) motor neuron-like cell lines. Wildtype
human SOD1 (SOD1Wt) and aLS-linked human mutant
SOD1G93a proteins were expressed in bacteria and purified to homogeneity as previously described [28]. Both
proteins were metallated to the extent that they were enzymically active [28]. each protein was labeled with alexa
Fluor 488 dye and then added to the culture medium of
NSC-34 cells at a concentration of 2 µg/mL. Using fluorescence microscopy, the uptake of both labeled SOD1Wt
and SOD1G93a was observed after 48 h (Fig. 1a), demonstrating that both SOD1Wt and mutant SOD1 can be
taken up by neuronal NSC-34 cells. the formation of
prominent inclusion-like structures was detected specifically after uptake of extracellular mutant SOD1 but not
SOD1Wt in NSC-34 cells. Furthermore, inhibitors of
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macropinocytosis [5-(N-ethyl-N-isopropyl)amiloride (eIPa)
and rottlerin] blocked the uptake of both SOD1Wt and
SOD1G93a by NSC-34 cells, in contrast to inhibitors of
clathrin mediated endocytosis [genistein and chlorpromazine hydrochloride (CPZ); Fig. S1]. this suggests that
both SOD1Wt and SOD1G93a are taken up by macropinocytosis into NSC-34 cells, as previously reported for
aggregated mutant SOD1 [1].
We then examined the uptake of extracellular SOD1
prepared in a mammalian baculovirus expression system. We transiently expressed GSt-tagged SOD1Wt and
SOD1G93a in Sf9 insect cells, which resulted in secretion
of SOD1 into the medium due to the presence of the aKh
signal peptide [29]. expression and secretion of SOD1
was confirmed at 48 h post-transfection by immunoblotting of the conditioned Sf9 medium with an anti-GSt
antibody (Fig. S2a). Furthermore, zymography confirmed
that both mutant and SOD1Wt retained enzymatic activity in the conditioned media, demonstrating that both
proteins were in their metallated, native form (Fig. S2B).
the Sf9 conditioned media was then applied to untransfected NSC-34 cells for 48 h. Immunocytochemistry using
an anti-GSt antibody revealed that GSt-tagged SOD1Wt
and SOD1G93a were taken up by NSC-34 cells (Fig. 1b).
however, there was no uptake in NSC-34 cells treated
with conditioned medium from insect cells expressing
GSt only, demonstrating that there was some specificity
in the uptake for SOD1. In cells treated with SOD1Wt conditioned medium, the fluorescence was uniform and dispersed throughout the cells. however, in cells treated with
mutant SOD1G93a, prominent fluorescent structures reminiscent of inclusions were present (Fig. 1b). hence both
natively folded SOD1Wt and SOD1G93a present in insect
cell conditioned media were taken up by NSC-34 cells,
and the uptake of SOD1G93a resulted in the formation of
intracellular SOD1 inclusions.
Uptake of extracellular recombinant mutant SOD1
activates eR stress in mouse NSC-34 cells
We next examined whether the uptake of extracellular
mutant SOD1 activates eR stress in NSC-34 cells. We first
examined whether the early phase of the UPR is activated
in cells treated with extracellular SOD1. Immunoblotting
for UPR markers IRe1, BiP and Xbp1 revealed an upregulation of all three proteins in cells treated with mutant
SOD1G93a compared to untreated cells or those treated with
SOD1Wt (Fig. 1c, d; threefold, P < 0.01). hence the early
phases of UPR are induced in cells treated with extracellular mutant SOD1G93a. We then examined cells for the later,
pro-apoptotic phase of UPR using immunocytochemistry
for nuclear ChOP [30, 31]. after 72 h treatment, a significant increase in nuclear ChOP immunoreactivity was

observed in NSC-34 cells treated with SOD1G93a compared
to untreated and SOD1Wt treated cells (Fig. 1e, f; twofold,
P < 0.001). hence the pro-apoptotic phase of UPR was
also triggered in mutant SOD1 treated cells. these findings were confirmed in NSC-34 cells treated with Sf9 cell
conditioned media. a significant upregulation in nuclear
ChOP immunoreactivity was detected on treatment with
Sf9 medium from SOD1G93a expressing cells compared to
SOD1Wt and GSt alone expressing cells (Fig. 1g; twofold,
P < 0.001). hence the uptake of extracellular mutant SOD1
expressed in either bacterial or a baculovirus system specifically induces eR stress, including pro-apoptotic ChOP,
in NSC-34 cells.
Uptake of extracellular aggregated SOD1Wt and SOD1G93a
by Sh-SY5Y human neuronal cells
We next asked whether uptake of aggregated/misfolded
SOD1Wt could induce aLS-like pathology in neuronal
cells. For this purpose a human neuroblastoma cell line
(Sh-SY5Y) was used due to the previously reported species specificity in seeding SOD1Wt aggregation [17].
aggregated recombinant SOD1Wt and mutant SOD1G93a
proteins were prepared by treatment with 5 mM eDta
and 50 mM Dtt to remove metal ions and reduce the
native Cys57-Cys146 SOD1 disulfide bond, respectively,
as described previously [28, 32–34]. the aggregated proteins (aggSOD1Wt, aggSOD1G93a) and native SOD1Wt and
SOD1G93a were then labeled with alexa Fluor 488 dye.
Silver staining of non-denaturing native gel and denaturing
SDS-PaGe gel revealed that both SOD1Wt and SOD1G93a
formed SDS-stable high molecular weight aggregates
(Fig. 2a, b).
Labeled aggSOD1Wt and aggSOD1G93a, and unaggregated SOD1Wt and SOD1G93a for comparison were then
added to the culture medium of Sh-SY5Y cells at a concentration of 2 µg/mL. Fluorescence microscopy revealed
that 48 h after treatment, Sh-SY5Y cells had taken up both
aggregated and unaggregated SOD1Wt and SOD1G93a from
the culture medium (Fig. 2c). Differential interference contrast (DIC) microscopy revealed the formation of membrane
ruffles in all cases, consistent with a macropinocytosis
mechanism for uptake of SOD1, as previously reported
for mutant SOD1 aggregates [1] (Fig. 2c). In cells treated
with SOD1G93a, aggSOD1Wt and aggSOD1G93a intracellular fluorescent inclusions were formed (20–30 % of cells;
Fig. 2d). Surprisingly, in a small proportion of cells (7 %)
treated with unaggregated native SOD1Wt, inclusions were
also present (Fig. 2d), which were never observed in murine
NSC-34 cells (Fig. 1a, b). Intracellular higher molecular
weight SOD1 aggregates were also present in cell lysates,
which were harvested after 0.125 % trypsin treatment of
the cells, to digest residual extracellular SOD1 aggregates
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(Fig. 2e). endogenous human SOD1 was clearly present
in untreated cells (Fig. 2e). however, in all cells treated
with extracellular SOD1, reduced levels of endogeneous
SOD1 was observed, and a corresponding increase in the
levels of high molecular weight aggregates was detected.
this finding implies that recruitment of endogenous SOD1

into higher molecular weight aggregates has occurred in
cells treated with aggregated SOD1Wt and mutant SOD1.
also, consistent with the microscopy findings, in unaggregated SOD1Wt treated cell lysates, SOD1 aggregates were
observed, although these aggregates ran at a faster mobility than those formed by mutant SOD1, suggesting they
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◂ Fig. 1 Uptake of extracellular mutant SOD1G93a triggers eR stress in

mouse NSC-34 cells. a Recombinant SOD1Wt and SOD1G93a (2 µg/
mL) labeled with alexa Fluor 488 dye (green) are taken up by NSC-34
cells 48 h after addition to medium. Nuclei are stained with DaPI
(blue). White arrows show the formation of inclusion-like structures
in cells treated with extracellular SOD1G93a. b extracellular GSttagged SOD1Wt and SOD1G93a (GSt-SOD1Wt, GSt-SOD1G93a) are
taken up by NSC-34 cells. Insect cell (Sf9) conditioned medium containing GSt-SOD1Wt, GSt-SOD1G93a or GSt only control (100 µg
total protein) was added to NSC-34 cells for 48 h. Cells were then
fixed and immunostained with anti-GSt antibody (green). No immunoreactivity was observed in cells treated with GSt alone (GSt) in
contrast to GSt-SOD1 treated cells. White arrow shows the formation of inclusion-like structures in cells treated with extracellular
GSt-SOD1G93a. c Immunoblotting reveals upregulation of UPR
markers IRe1, BiP, and spliced Xbp1 in NSC-34 cells 72 h after
treatment with recombinant purified SOD1G93a, in contrast to cells
treated with recombinant SOD1 Wt and untreated (Ut) cells (20 µg/
lane). as a positive control NSC-34 cells were treated with 10 µM
thapsigargin to induce eR stress (thaPS) for 1 h before lysis. β-actin
was used as a loading control. d Densitometric analysis of the immunoblots relative to β-actin intensity confirms upregulation of all three
UPR markers in NSC-34 cells treated with recombinant SOD1G93a.
e Representative images showing increased nuclear immunoreactivity to pro-apoptotic, eR stress-specific ChOP (red) in NSC-34 cells
treated with SOD1G93a for 72 h. Nuclei are stained with DaPI (blue).
f Quantification of NSC-34 cells containing nuclear immunoreactivity to ChOP 72 h after treatment with recombinant, purified SOD1
(SOD1Wt, SOD1G93a) and untreated cells (Ut). g Quantification of
NSC-34 cells containing nuclear immunoreactivity to ChOP 72 h
after treatment with Sf9 insect cell conditioned medium containing
GSt-SOD1 (GSt-SOD1Wt, GSt-SOD1G93a) or GSt alone. Results
are expressed as mean ± SeM; n = 3; **P < 0.01, ***P < 0.001 versus SOD1Wt and untreated cells (Ut) (f) or SOD1Wt or GSt treated
cells (g) as indicated by one-way aNOVa with tukey’s post-test,
n = 3. all scale bars represent 10 µm

are smaller than those in other cell populations. hence
misfolded/aggregated SOD1Wt and mutant SOD1 are
taken up by human neuronal cells, leading to intracellular
SOD1 aggregation and possible recruitment of endogenous
SOD1. Induction of SOD1 aggregation by natively folded
SOD1Wt was also detected in a small proportion of cells.
Uptake of extracellular aggregated SOD1Wt and SOD1G93a
activates eR stress in Sh-SY5Y cells
We next examined whether eR stress is activated in
Sh-SY5Y cells treated with extracellular SOD1G93a,
aggSOD1Wt and aggSOD1G93a for 72 h. Immunoblotting
for IRe1, BiP and spliced Xbp1, revealed that the UPR
was induced (Fig. 3a, b; twofold, P < 0.01) in Sh-SY5Y
cells treated with aggregated and unaggregated SOD1G93a
compared to untreated cells, consistent with the findings in NSC-34 cells. Furthermore, in cells treated with
aggSOD1Wt, induction of the UPR was also observed,
demonstrating that SOD1Wt can also trigger eR stress
when misfolded. Surprisingly we also observed a slight
but significant upregulation of Xbp1 (P < 0.05) in cells

treated with unaggregated SOD1Wt compared to untreated
cells. Similarly, using immunocytochemistry, a significant
increase in nuclear ChOP in Sh-SY5Y cells treated with
SOD1G93a, aggSOD1Wt and aggSOD1G93a treated cells
compared to untreated cells was detected (Fig. 3c, d; threefold, P < 0.001). hence uptake of extracellular aggregated
SOD1 induces the eR stress-specific pro-apoptotic phase of
UPR in Sh-SY5Y cells, similar to mutant SOD1. Consistent with the immunoblotting results, we observed a modest
but significant increase in nuclear ChOP immunoreactivity
in cells treated with unaggregated SOD1Wt (P < 0.05) compared to untreated cells. In contrast, neither bacterial nor
baculovirus SOD1Wt induced eR stress in NSC-34 cells
(Fig. 1c). hence extracellular, native SOD1Wt induces eR
stress in the Sh-SY5Y human cell line but not the NSC-34
mouse neuronal cell line.
extracellular aggregated SOD1Wt and SOD1G93a inhibits
eR to Golgi protein trafficking and induces Golgi
fragmentation
We next examined whether extracellular misfolded or
mutant SOD1 could also inhibit eR to Golgi protein trafficking. Vesicular stomatitis virus glycoprotein ts045
(VSVG-ts045) is a widely employed marker used to examine eR–Golgi transport [35]. VSVG-ts045 misfolds and is
retained in the eR at 40 °C, but is transported to the Golgi
apparatus at the permissive temperature of 32 °C [35].
We first examined eR–Golgi transport in Sh-SY5Y cells
transfected with SOD1 proteins linked to eGFP [6, 12] and
VSVG-ts045 mCherry, to confirm that intracellular mutant
SOD1 can inhibit eR–Golgi trafficking in this cell line.
VSVG-ts045 was detected immunocytochemically using
markers of the eR (calnexin) and Golgi (GM130) and its
co-localization with each marker was quantified using
Mander’s coefficient [36]. at 32 °C, VSVG-ts045 was
transported to the Golgi in untransfected cells and in cells
expressing SOD1Wt (Fig. S3a). however, in cells expressing mutant SOD1 (Fig. S3a) most VSVG-ts045 remained
in the eR and significantly less (~50 %) was transported
to the Golgi (Fig. S3B; P < 0.01). hence eR–Golgi trafficking is inhibited by intracellular mutant SOD1 in the
Sh-SY5Y cell line (Fig. S3a, S3B). We next examined
eR–Golgi transport in cells treated with extracellular SOD1
proteins. Sh-SY5Y cells were transiently transfected with
VSVG-ts045 mCherry. at 24 h post-transfection, 2 µg/
mL of purified, labeled SOD1Wt, SOD1G93a, aggSOD1Wt
and aggSOD1G93a were added to the Sh-SY5Y medium
for another 48 h. transport of VSVG-ts045 from the eR to
Golgi was then examined using immunocytochemistry to
calnexin and GM130 as above. Quantification of the degree
of co-localization of VSVG-ts045 with eR and Golgi compartments using Mander’s coefficient was then performed.
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VSVG-ts045 was efficiently transported to the Golgi apparatus in untreated cells after 60 min at 32 °C. however,
in cells treated with extracellular SOD1G93a, aggSOD1Wt
or aggSOD1G93a, VSVG-ts045 was retained in the eR and
significantly less was transported to the Golgi (P < 0.001)
compared to untreated cells (Fig. 4a–c). hence extracellular mutant SOD1 inhibits eR–Golgi transport similar to
intracellular mutant SOD1. these findings were confirmed
using NSC-34 cells treated with extracellular SOD1G93a

(Fig. 4d). Furthermore, aggSOD1Wt also inhibited eR
to Golgi protein trafficking in Sh-SY5Y cells, to a level
comparable to both SOD1G93a and aggSOD1G93a. hence
both mutant and aggregated SOD1 inhibit eR–Golgi transport. there was no significant difference in the transport
of VSVG-ts045 from eR–Golgi in NSC-34 cells treated
with native SOD1Wt compared to Ut cells. a slight difference was observed in Sh-SY5Y cells treated with
native SOD1Wt, but this was not statistically significant
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◂ Fig. 2 Uptake and aggregation of extracellular mutant SOD1G93a

and aggregated SOD1Wt in Sh-SY5Y cells. a Recombinant purified SOD1Wt and SOD1G93a proteins were aggregated by treatment
with 50 mM Dtt and 5 mM eDta at 37 °C for 72 h and labeled
with alexa Fluor 488 dye. the formation of aggregates was confirmed by 10 % native gel electrophoresis (1 µg/lane) followed by
silver staining. b Silver stained SDS PaGe of SOD1 aggregates
with 100 mM Iodoacetamide, revealed the presence of SDS stable
higher molecular weight Wtagg488 and G93aagg488 aggregates, as
indicated. c Native and aggregated SOD1Wt and SOD1G93a labeled
proteins were added to the Sh-SY5Y cell culture medium at a concentration of 2 µg/mL. after 48 h treatment, the cells were fixed and
examined by fluorescence microscopy (SOD1 488, green), after staining the nuclei with DaPI (blue). Representative images show the
uptake of extracellular protein in each case. Intracellular fluorescent
SOD1 inclusions were abundant in mutant SOD1 and aggregated
SOD1 treated cells, and were present in a small proportion of native
SOD1Wt treated cells. DIC images (panel 3 from left, white arrows)
show the formation of membrane ruffles characteristic of macropinocytosis in each case. all scale bars represent 10 µm. d Quantification
of SOD1 inclusion formation in Sh-SY5Y cells 48 h after treatment
(Ut, SOD1Wt, SOD1G93a, SOD1Wtagg, SOD1G93aagg). SOD1 inclusions were defined as fluorescent, inclusion-like structures greater
than 1 µm in diameter and were quantified using ImageJ. Results are
expressed as mean ± SeM; n = 3; **P < 0.01, ***P < 0.001 versus
Ut by one-way aNOVa with tukey’s post-test. e Following extracellular protein treatment for 48 h, Sh-SY5Y cell lysates were collected after 0.125 % trypsin digestion of cells to remove the residual
extracellular SOD1 inoculum and run on 10 % native PaGe. high
molecular weight intracellular SOD1 aggregates were present in all
lysates except Ut cells as indicated. endogeneous human Sh-SY5Y
SOD1 can be seen in Ut, but this band is reduced in cells treated with
native SOD1Wt, indicating the recruitment of endogenous SOD1 into
the high molecular weight aggregates. Similarly, this band is further
decreased in cells treated with G93a, Wtagg and G93aagg compared
to both Ut and SOD1Wt

(Fig. 4a–c). Consistent with these findings, extracellular
mutant SOD1 did not co-localise with eR markers after
uptake into NSC-34 cells (Fig S4). hence these data suggest that extracellular SOD1 triggers eR stress from the
cytoplasm following uptake into neuronal cells, by inhibiting the transport of secretory proteins from the eR to
Golgi.
Inhibition of eR–Golgi transport implies disruption to
the secretory pathway. hence fragmentation of the Golgi
apparatus was next examined in Sh-SY5Y cells treated
with extracellular SOD1, by immunostaining with antiGM130 antibody. In untreated cells the Golgi apparatus
mostly localized to a compact, perinuclear ribbon. In contrast, the Golgi apparatus fragmented into condensed punctate structures in 25–40 % of cells treated with SOD1G93a,
aggSOD1Wt and aggSOD1G93a (Fig. 5a, c). Similarly,
Golgi fragmentation was also detected in 25 % of NSC34 cells treated with extracellular SOD1G93a (Fig. 5b, d;
P < 0.05). the Golgi was fragmented in a smaller but significant percentage of Sh-SY5Y cells (P < 0.05) treated
with native SOD1Wt, but not in NSC-34 cells treated with
native SOD1Wt (Fig. 5c, d).

Uptake of extracellular aggregated SOD1Wt or mutant
SOD1 induces cell death in Sh-SY5Y cells
Prolonged eR stress and induction of ChOP implies that
apoptotic cell death is triggered in cells treated with extracellular SOD1. hence we next examined induction of apoptosis using annexin V/propidium iodide (PI) staining by
flow cytometry [37]. after 72 h treatment with extracellular
SOD1, apoptotic cell death was quantified using FaCS. In
Sh-SY5Y cells there was a significant increase (P < 0.05)
in the percentage of cells undergoing apoptosis after treatment with aggSOD1Wt, SOD1G93a and aggSOD1G93a compared to untreated cells (Fig. 6a, b). treatment with aggregated forms of SOD1Wt and SOD1G93a induced apoptosis
in a higher percentage of cells compared to the respective
native forms (P < 0.05). hence apoptosis is triggered by
extracellular misfolded SOD1 proteins in Sh-SY5Y cells.
however, there were no significant differences in the percentage of cells undergoing apoptosis in NSC-34 cells after
treatment with extracellular SOD1Wt and SOD1G93a compared to the controls (Fig. 6c).

Discussion
this study provides clear evidence that the uptake of
extracellular misfolded SOD1 into neuronal cells initiates
neurodegenerative pathways reminiscent of aLS pathology. Misfolded SOD1Wt and mutant SOD1 were taken up
by neuronal cells, inducing the formation of intracellular
SOD1-positive inclusions. this triggered inhibition of transport from the eR to Golgi apparatus, eR stress, fragmentation of the Golgi and neuronal cell death, implying that
extracellular SOD1 may be responsible for the spread of
neurodegeneration among motor neurons in aLS. Moreover, both mutant SOD1 and aggregated SOD1Wt displayed
a similar ability to induce these effects, thus providing clues
into the pathology of both familial and sporadic aLS.
this study also demonstrates that the uptake of extracellular SOD1 does not depend on the presence of a
mutation or aggregation. extracellular SOD1Wt was
taken up by murine NSC-34 cells, which did not induce
pathology. a previous study demonstrated that extracellular, aggregated mutant SOD1 is taken up by macropinocytosis, a mechanism of non-selective endocytosis of
macromolecules from the extracellular space [1]. the
findings of our study are consistent with this mechanism because both natively folded and aggregates of
SOD1Wt and mutant SOD1 were taken up to a similar
degree. also, inhibitors of macropinocytosis were able to
block the uptake of SOD1Wt and SOD1G93a into NSC34 cells. Furthermore, membrane ruffles characteristic of
macropinocytosis were present in Sh-SY5Y cells after
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Fig. 3 Uptake of extracellular, aggregated SOD1Wt and mutant
SOD1 activates eR stress in Sh-SY5Y cells. a Immunoblotting of
cell lysates from Sh-SY5Y cells treated with extracellular proteins
SOD1G93a, Wtagg, and G93aagg reveals upregulation of UPR markers
IRe1, BiP, and spliced Xbp1 after 72 h treatment (20 µg/lane). as a
positive control, cells were treated with 10 µM thapsigargin (thaPS)
for 1 h before lysis to induce eR stress. β-actin was used as a loading control. b Densitometric quantification of immunoblots relative to
β-actin intensity reveals upregulation of all three UPR markers in cells
treated with SOD1G93a, Wtagg, and G93aagg compared to Ut cells.
Results are expressed as mean ± SeM; n = 3; *P < 0.05, **P < 0.01,

***P < 0.001 versus untreated cells or SOD1Wt treated cells as indicated, by one-way aNOVa with tukey’s post-test. c Representative
fluorescent microscopy images demonstrate nuclear immunoreactivity to ChOP (red), indicating activation of ChOP and hence eR
stress, 72 h after treatment with Wt, G93a, Wtagg, G93aagg SOD1.
all scale bars represent 10 µm. d Quantification of the proportion of
Sh-SY5Y cells with nuclear ChOP immunoreactivity in (c), 72 h
after treatment with Wt, G93a, Wtagg and G93aagg. Results are
expressed as mean ± SeM; n = 3; *P < 0.05, ***P < 0.001 versus
Ut by one-way aNOVa with tukey’s post-test
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treatment with extracellular SOD1 [38–40]. Our findings imply that secretion or simple diffusion of misfolded
SOD1 into CSF by affected cells (including astrocytes
and microglia, as well as motor neurons) could be subsequently endocytosed by neighboring motor neurons, thus
inducing neurodegeneration. as aLS is now considered
as a multi-system disorder where there is an interplay
between motor neurons and other neuronal cell types [41,
42], uptake of misfolded or mutant SOD1 by neuronal
cells would therefore explain the neurospatial spread of
pathology in human aLS. Consistent with this notion,
misfolded SOD1 has been identified in the CSF of sporadic and familial aLS patients [14, 15]. even low levels of misfolded SOD1 in CSF could seed intracellular
aggregation after uptake [14], subsequently spreading
pathology.
aggregated forms of SOD1Wt induced similar cellular
pathogenic effects to mutant SOD1 in this study. Furthermore, we observed the formation of inclusions in a small
proportion of Sh-SY5Y cells treated with native SOD1Wt,
which were never present in NSC-34 cells. Metal-free
forms of SOD1 have been proposed to be the toxic precursor preceding aggregation in familial aLS [43, 44]. the
majority of aLS mutations affect the structural stability of
SOD1, leading to the exposure of buried hydrophobic residues, thus resulting in aggregation [45]. hence SOD1Wt
has an intrinsic propensity to aggregate which is enhanced
by mutation. Previous studies have demonstrated that
misfolded, oxidized SOD1Wt is as pathogenic as mutant
SOD1 [16]. however, we observed pathological effects
induced by extracellular native SOD1Wt in human ShSY5Y cells not previously observed in murine NSC-34
cells or by intracellular expression of SOD1Wt. the reason
for this is unclear, but it is possible that native SOD1Wt
recruits endogeneous human SOD1 into aggregates after
uptake in Sh-SY5Y cells. this would explain the lower
but significant inclusion formation, activation of eR stress
and Golgi fragmentation in Sh-SY5Y cells treated with
unaggregated, extracellular SOD1Wt. Both recombinant,
purified SOD1Wt from Escherichia coli, or Sf9 medium
containing SOD1Wt, were taken up by NSC-34 cells, but
neither induced eR stress, or aggregate/inclusion formation. Similarly, we detected apoptosis in Sh-SY5Y cells
but not NSC-34 cells treated with extracellular SOD1.
these data are consistent with the notion that there is species specificity in the recruitment of SOD1 misfolding
[17], thus implicating a gain of toxic function by SOD1Wt
in the presence of human SOD1. Indeed, overexpression of
SOD1Wt induces misfolding of endogenous SOD1 in the
same cell line [17]. We also observed that the addition of
extracellular SOD1 results in the rapid formation of intracellular SOD1 aggregates in the cytoplasm after uptake.
this replicates the commonly described observation that

over-expression of mutant SOD1 in cell culture results
in the rapid formation of aggregates. In contrast, aggregates appear much later in mouse aLS models based on
transgenic over-expression of mutant SOD1, generally at
the end stages of disease [11, 46], thus highlighting differences observed between animal and cellular disease
models.
eR stress is now established as a key pathway to cell
death in aLS [7, 8, 23, 31]. Mutant SOD1 induces eR
stress [6] and Golgi fragmentation [26] in neuronal cell
cultures, and we now show that aggregated SOD1Wt
induces UPR and Golgi fragmentation similar to mutant
SOD1. these findings are consistent with recent evidence
for common pathogenic pathways shared by mutant
SOD1 and SOD1Wt, and the presence of misfolded
SOD1Wt in sporadic aLS tissues [4, 5]. It is unclear how
eR stress is triggered in aLS because SOD1 is normally
located in the cytoplasm and reports that it is found in
microsomes [47] have been subsequently challenged
[23]. however, it was previously proposed that eR stress
in aLS is triggered by cytoplasmic SOD1 [23]. We show
here that extracellular SOD1 does not co-localise with
eR markers after uptake, consistent with the notion that
eR stress is triggered from the cytoplasm. however, eR
stress can be caused by failure of eR–Golgi trafficking
[24, 25]. We also confirm here that intracellular mutant
SOD1 inhibits the transport of VSVG-ts045 from the eR
to Golgi in Sh-SY5Y cells, and we show that extracellular forms of mutant and aggregated SOD1Wt also delay
eR–Golgi traffic, thus providing one possible explanation
for induction of eR stress. Similarly, Golgi fragmentation is also triggered by an imbalance between anterograde and retrograde traffic between eR and Golgi [26],
highlighting a possible role for disruption to eR–Golgi
traffic in both events. the activation of pro-apoptotic
ChOP and increase in the proportion of cells undergoing
apoptosis in cells treated with extracellular SOD1 provides a link between extracellular proteins and neurodegeneration and UPR-specific cell death. hence this study
also provides further evidence linking the disruption of
eR–Golgi compartments to aLS and shows that extracellular misfolded proteins can induce dysfunction in these
organelles.
In conclusion, this study establishes mechanisms of
toxicity induced by extracellular SOD1 applicable to both
sporadic and familial aLS. Our findings are consistent with
a prion-like propagation of neurotoxicity in aLS, and they
provide further evidence for common neurodegenerative
pathways shared by mutant and SOD1Wt linked to the eR–
Golgi compartments. the demonstration of specific, cellular pathways targeted by extracellular, misfolded SOD1
also provides novel targets for ameliorating the spread of
neurodegeneration in aLS.
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Materials and methods
expression and purification of recombinant SOD1
human SOD1Wt and SOD1G93a were expressed and purified from E. coli as previously described [28, 48]. Briefly,
E. coli cells were cultured at 23 °C with 3 mM CuSO4 and

30 µM ZnSO4 for metal loading. SOD1Wt and SOD1G93a
proteins were then purified from bacterial lysates, by heat
denaturation, size exclusion chromatography (Superdex
75; Ge healthcare), and anion-exchange chromatography
using a Q-Sepharose anion exchange column (Ge healthcare), and eluted with a salt gradient of 0–125 mM NaCl,
ph 7.5 [28].
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◂ Fig. 4 Uptake of extracellular, aggregated Wt and mutant SOD1
inhibits eR to Golgi protein trafficking in Sh-SY5Y cells. Cells
expressing VSVG-ts045 mCherry were treated with Wt, G93a,
Wtagg, G93a agg at 24 h post transfection. after trapping VSVGts045 mCherry in the eR by incubation at 40 °C for 24 h, the temperature was shifted to 32 °C for 60 min or fixed immediately at
0 min. the cells were then stained with calnexin (blue), a marker of
the eR, or GM130 (blue), a marker of the Golgi apparatus. a Representative fluorescent images of cells expressing VSVG-ts045 (red)
treated with Wt, G93a, Wtagg, G93aagg SOD1 protein (green) and
Ut cells after incubation at 40 °C (0 min). b Representative fluorescent images after 60 min incubation at 32 °C. VSVG is co-localised with GM130 in cells treated with native SOD1Wt and Ut cells
in contrast to cells treated with Wtagg, G93a, G93a agg, in which
VSVG is still predominantly co-localised with calnexin, indicating an inhibition of VSVG-ts045 transport from eR to Golgi. all
scale bars 10 µm. c Quantification of the degree of co-localisation of VSVG-ts045 with calnexin and GM130 at 60 min as in b
using Mander’s coefficient. Data are presented as mean ±
SeM,
***P < 0.001 versus Ut by one-way aNOVa with tukey’s posttest, n = 3. d Uptake of extracellular mutant SOD1 inhibits eR to
Golgi protein trafficking in NSC-34 cells. Cells expressing VSVGts045 mCherry were treated with recombinant, labelled SOD1Wt
or SOD1 G93a at 24 h post transfection. after trapping VSVG-ts045
mCherry in the eR by incubation at 40 °C for 24 h, the temperature was shifted to 32 °C for 0 and 30 min. the degree of co-localisation of VSVG-ts045 with calnexin and GM130 was quantified
using Mander’s coefficient. Data are presented as mean ± SeM,
***P < 0.001 versus SOD1Wt treated or Ut cells as indicated by
one-way aNOVa with tukey’s post-test, n = 3

expression of SOD1 from Sf9 baculoviral system
human SOD1Wt and SOD1G93a constructs were generated by PCR and cloned into pIeX-3 plasmids using SpeI
restriction sites. Spodoptera frugiperda (Sf9) cells were
kindly provided by Dr. Mark hulett, La trobe University.
the cells were cultured at 28 °C and transfected using
GeneJuice transfection reagent (Invitrogen) as per the
manufacturer’s protocol. 48 h after transfection the culture
medium was collected after centrifugation at 1200 rpm for
5 min and analyzed by immunoblotting.
Zymography–SOD1 activity assay
For zymography, SOD1 protein samples were electrophoresed
on a 10 % native PaGe. the gel was then soaked in 2.45 mM
nitro blue tetrazolium (Sigma) for 20 min, washed with dh2O
and soaked in developer solution containing 28 mM tetramethylehylenediamine (teMeD; BIO-RaD), 28 µM riboflavin, and 36 mM Kh2PO4 (Sigma) for 15 min. the gel was
illuminated for 5–15 min until sufficient contrast between achromatic zones and blue background was achieved.
aggregation and labeling of SOD1Wt and mutant
SOD1G93a
In vitro SOD1 aggregation was performed as previously
described [28]. Purified SOD1Wt and G93a SOD1 proteins

(1 mg/mL) dissolved in PBS were incubated with 50 mM
dithiothreitol (Dtt) and 5 mM ethylenediaminetetraacetic
acid (eDta) at 37 °C for 72 h whilst shaking and vortexed
briefly to obtain a homogenous solution. aggregated and
native SOD1Wt and SOD1G93a were then labeled using the
alexa Fluor 488 Microscale Protein Labeling Kit (Invitrogen). Protein (100 µg) was incubated with dye in the presence of 100 mM NahCO3 at room temp for 15 min. the
unlabeled protein was then separated using amicon Ultra
10 kDa centrifugal filters (Millipore).
extracellular SOD1 treatment
Mouse motor neuron-like NSC-34 or human neuroblastoma
Sh-SY5Y cells were cultured on 24 well plates with or without 13 mm coverslips at 105 cells/well. Purified recombinant
SOD1 (2 µg/mL) expressed in bacteria was added to the
culture medium 24 h after seeding, and 48 h later the cells
were analyzed by immunocytochemistry or immunoblotting.
For cells treated with Sf9 conditioned medium containing
GSt-SOD1 or GSt-only control, medium containing 100 µg
total protein was added to the NSC-34 culture medium to a
final concentration of 0.2 mg/mL.
SOD1 uptake and inhibition
NSC34 cells were cultured on coverslips for 24 h before
treatment with either 3 µM rottlerin D, 100 µM eIPa,
10 µM genistein or 5 µM chlorpromazine hCL for 30 min
at 4 °C. these cells were then treated with SOD1Wt or
SOD1G93a or untreated at 4 °C for 30 min before being
washed with PBS. the cells were then fixed with 4 % PFa
and incubated with 0.5 % BSa in PBS for 20 min at room
temperature. a 1:500 dilution of anti-human SOD1 sheep
antiserum (thermo Fisher Scientific) in PBS containing 0.1 % BSa and subsequent goat anti-sheep alexa488
(Invitrogen) was used to detect internalized SOD1. SOD1
was visualized using a Leica SP5 scanning confocal
microscope.
Immunocytochemistry
NSC-34 or Sh-SY5Y cells grown on coverslips were
washed with PBS and fixed with 4 % paraformaldehyde
(PFa; Merck) in PBS for 10 min. Cells were permeabilized
in 0.1 % triton X-100 in PBS for 2 min, blocked for 30 min
with 1 % BSa in PBS and incubated with the appropriate
primary antibodies as follows for 16 h at 4 °C: anti-ChOP
(1:50; Santa Cruz), anti-GM130 (1:50; BD transduction
Laboratories™), anti-Calnexin (1:100; abcam) or antiGSt (MBB lab; La trobe University). Secondary alexaFluor-594 or 644 conjugated anti-mouse or anti-Rabbit
antibodies (1:2000; Molecular Probes) were incubated for
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Fig. 5 Uptake of extracellular, aggregated SOD1Wt and mutant
SOD1 induces Golgi fragmentation in Sh-SY5Y and NSC-34 cells.
Sh-SY5Y cells treated with extracellular Wt, G93a, Wtagg, G93aagg
SOD1 or NSC-34 cells treated with SOD1Wt and SOD1G93a were
fixed with 4 % PFa after 72 h treatment and immunostained with
anti-GM130 antibody. a Representative images of Sh-SY5Y cells
treated with Wt, G93a, Wtagg, G93aagg SOD1 (green). Cells were
stained with anti-GM130 antibody (red) and nuclei were stained
with DaPI (blue). Arrows indicate fragmented Golgi, indicated by
condensed punctate structures in contrast to intact Golgi (Ut cells).
b Representative images of NSC-34 cells stained with GM130 (red)

showing fragmented Golgi after treatment with mutant SOD1G93a. all
scale bars represent 10 µm. c Quantification of cells with fragmented
Golgi in Sh-SY5Y cells upon treatment with extracellular Wt,
G93a, Wtagg, G93aagg SOD1 for 72 h. d Quantification of cells with
fragmented Golgi in NSC-34 cells 72 h after treatment with extracellular SOD1Wt and SOD1G93a. there is no significant difference in
the proportion of NSC-34 cells with fragmented Golgi in extracellular SOD1Wt treated cells compared to Ut cells, in contrast to ShSY5Y cells. Results are expressed as mean ± SeM; n = 3; *P < 0.05,
**P < 0.01, ***P < 0.001 versus Ut cells by one-way aNOVa with
tukey’s post-test

1 h at room temperature, cells were then treated with hoechst 33342 (Invitrogen) and mounted on slides using fluorescent mounting medium (Dako). Images were acquired
using constant gain and offset settings for ChOP using an
Olympus fluorescence microscope at 40× magnification.
Induction of eR stress was assessed by examining individual cells for nuclear immunoreactivity to ChOP. For
each treatment, 100 cells from three different experiments
were scored. Fragmentation of the Golgi apparatus was

determined by staining with the anti-GM130 antibody. the
number of cells with fragmented Golgi per 100 cells from
three different experiments was scored by fluorescence
microscopy.
Protein extraction
the cells were washed with PBS and lysed with tN buffer
(50 mM tris–hCl ph 7.5, 150 mM NaCl, 0.1 % SDS) with
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Fig. 6 Uptake of extracellular
aggregated SOD1Wt and mutant
SOD1 induces apoptotic cell
death in Sh-SY5Y cells but
not NSC-34 cells. a Sh-SY5Y
cells treated with extracellular
Wt, G93a, Wtagg and G93aagg
SOD1 for 72 h were harvested,
stained with PI/annexin V
and the percentage of cells in
both early and late apoptotic
phase was gated and scored by
flow cytometry, as indicated
by cells stained with both PI
and annexin V. b Percentage of apoptotic cells among
cells treated with Wt, G93a,
Wtagg and G93aagg and Ut
cells. Results are expressed as
mean ± SeM; n = 3; *P < 0.05,
**P < 0.01, ***P < 0.001 versus untreated cells by one-way
aNOVa with tukey’s post-test,
n = 3. c NSC-34 cells treated
with extracellular SOD1Wt and
SOD1G93a for 72 h were stained
with PI/annexin V and analysed
by flow cytometry. Incontrast to
Sh-SY5Y cells, no significant
percentage (>5 %) of apoptotic
cells were identified in NSC-34
after treatment with SOD1G93a.
NSC-34 cells were treated with
10 µM thapsigargin (thaPS)
for 4 h before harvesting as a
positive control

1 % protease inhibitor (Sigma), followed by incubation on
ice for 10 min. the SDS soluble protein fraction was collected by centrifugation at 16 100 g for 10 min. For immunoblotting, the cells were also treated with 0.125 % trypsin
for 2 min at room temperature before lysis, to remove
residual extracellular SOD1.
Immunoblotting
Protein samples (20 µg) electrophoresed through 10 %
SDS–polyacrylamide gels or 10 % native PaGe (nondenaturing) gels and transferred to nitrocellulose membranes (Millipore). For the SDS-PaGe analysis of SOD1
aggregates, the samples were prepared in sample loading
buffer (0.042 M tris–hCl, 2 % SDS, 1 % glycine, 0.005 %
bromophenol blue, 10 % glycerol, 100 mM iodoacetamide,

4 % freshly added β mercaptoethanol). Membranes were
blocked with 3 % (w/v) bovine serum albumin (BSa;
Sigma), ph 8.0 for 1 h. the appropriate primary antibodies
were prepared in 1 % (w/v) BSa solution as follows: SOD1
(1:1000; Calbiochem), BiP (1:4000; Stressgen), Xbp1
(1:400; SC), IRe1 (1:600; SC) and β actin as a loading control (1:750; Sigma-aldrich). all antibodies were incubated
with membranes for 1 h at room temperature (Rt). Blots
were probed with hRP-conjugated donkey anti-sheep, goat
anti-rabbit or goat anti-mouse antibodies at 1:2500 (Chemicon) for 1 h at Rt and then developed using enhanced
chemiluminescence (eCL) reagents (Roche). Quantification of band intensities was performed by densitometric
analysis following subtraction of background using Image
J (National Institutes of health, Bethesda, Ma, USa) and
expressed relative to the corresponding signal for β-actin.
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Blots were stripped using Reblot Plus solution (Chemicon)
for 15 min, and then reprobed as above.
VSVG transport assay
Sh-SY5Y or NSC-34 cells were plated on 24-well plates
with 13 mm coverslips. after 24 h in culture, cells were transfected with VSVG-ts045 tagged with fluorescent mCherry
(a kind gift from Dr. Jennifer Lippincott-Schwartz and Dr.
George Patterson) and another 24 h later cells were treated
with extracellular SOD1 protein [35]. Following treatment
for 24 h, cells were incubated at 40 °C for 24 h to accumulate VSVG-ts045 in the eR. Cycloheximide (20 µg/mL)
was then added, and cells were shifted to 32 °C for 60 min
or immediately fixed at 0 min. at each time interval, cells
were washed with ice-cold PBS and fixed with 4 % PFa.
the eR and Golgi compartments were immunostained
with rabbit polyclonal anti-Calnexin antibody (abcam) and
mouse monoclonal anti-GM130 antibody (BD transduction Laboratories™) as described above. In each experiment
20 cells were scored, and all experiments were performed
in triplicate. Image analysis was performed using Image J
using the JaCoP plugin to threshold and collect the Mander’s coefficient [36] between the mCherry and far-red
channels.
annexin V binding assay to detect apoptotic cell death
Sh-SY5Y cells cultured in six-well plates were treated
with extracellular SOD1 protein as above. the cells were
harvested after 72 h treatment by adding trypsin for 1 min
at room temperature. the cells were then collected in
PBS, centrifuged at 1200 rpm for 5 min, and resuspended
in 200 µl of annexin V binding buffer (10 mM hePeS,
140 mM NaCl, 2.5 mM CaCl2, ph 7.4). the cell suspension was treated with 3 µl of annexin V dye (Invitrogen)
at room temperature for 15 min in the dark. annexin V
binding buffer (100 µl) was then added to the cell suspension, counter-stained with 5 µg/mL of propidium iodide
(PI, Sigma) and analyzed by BD FaCS Canto II flow
cytometer.
Statistical analyses
Data are presented as mean ± standard error of the mean
(SeM) from at least three independent experiments and
were analyzed by one-way aNOVa followed by tukey’s
post hoc test using Prism 5.0 GraphPad Software. a value
of P < 0.05 was considered significant.
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